Clinical Trials on Amphetamine Use Disorders

Total 143829 results

Laureate Institute for Brain Research, Inc.

Completed

Transcranial Direct Current Stimulation to Modulate Top-Down Regulation for Drug Craving in Methamphetamine Use Disorder (NeuroMethDC)

Amphetamine Use Disorders

United States
Shanghai Mental Health Center

Completed

Transcranial Magnetic Stimulation for Treatment of Methamphetamine Use Disorder

Amphetamine Use Disorders

China
Laureate Institute for Brain Research, Inc.

Recruiting

Floatation-REST in Methamphetamine Use Disorder: A Pilot Study

Amphetamine-Type Substance Use Disorder

United States
University of California, San Francisco

Completed

Oxytocin HIV Meth Study (OHM)

Amphetamine Use Disorders

United States
Laureate Institute for Brain Research, Inc.
Oklahoma Center for the Advancement of Science and Technology

Completed

Neurocognitive Empowerment for Addiction Treatment (NEAT) in Opioid Use Disorder and Amphetamine Use Disorder (NEAT)

Opioid-use Disorder | Amphetamine Use Disorders

United States
National Institute on Drug Abuse (NIDA)

Unknown

Effects of Stimulant Dependence on Human Striatal Dopamine System - 15

Tobacco Use Disorder | Amphetamine-Related Disorders

United States
Shanghai Mental Health Center

Recruiting

Individualized Neuromodulation for the Core Clinical Features of Drug Addiction

Amphetamine Use Disorders

China
National Taiwan University Hospital

Unknown

Combination of Psychosocial Intervention and Slow Prosecutions for the Treatment of Methamphetamine Abuse/Dependence

Methamphetamine Dependence | Methamphetamine Abuse | Amphetamine Dependence | Amphetamine Abuse

Taiwan
University of Texas Southwestern Medical Center
Stanley Medical Research Institute

Completed

A Pilot Study of Citicoline add-on Therapy in Patients With Bipolar Disorder or Major Depressive Disorder and Amphetamine Abuse or Dependence

Bipolar Disorder | Major Depressive Disorder | Amphetamine Dependence | Amphetamine Abuse

United States
University of Pennsylvania
National Institute on Drug Abuse (NIDA); Society of Alcoholism and other Addictions

Completed

Extended Release Naltrexone for Treating Amphetamine Dependence in Iceland

Amphetamine Dependence

Iceland
Shanghai Mental Health Center

Completed

The Diagnostic Assessment and Intervention Study of Amphetamine Type Stimulus

Amphetamine Addiction

China
Centre hospitalier de l'Université de Montréal...

Withdrawn

Cannabioids as a New Intervention for Amphetamine Dependence

Amphetamine Addiction

Canada
Shanghai Mental Health Center

Completed

The Application of Music Therapy in Female Amphetamine Use Disorder

Amphetamine Addiction

China
University of Virginia
American Association of Chairs of Departments of Psychiatry

Withdrawn

Dose Response of Mirtazapine to Methamphetamine Induced Interest, Mood Elevation and Reward

Amphetamine Dependence

United States
The University of New South Wales
St Vincent's Hospital, Sydney; Australian Government Department of Health and... and other collaborators

Unknown

Trial of Modafinil for Methamphetamine Dependence

Amphetamine Dependence

Australia
Shanghai Mental Health Center

Recruiting

Robot-Assisted Intelligent Rehabilitation Treatment for Methamphetamine Use Disorders.

Amphetamine Addiction

China
Friends Research Institute, Inc.
National Institute on Drug Abuse (NIDA)

Completed

Long-term Behavior Change - 1

Amphetamine-related Disorders

United States
California Pacific Medical Center Research Institute

Unknown

A Dose Ranging Study of Modafinil for Methamphetamine Dependence

Substance Dependence | Amphetamine Dependence

United States
University Hospital, Basel, Switzerland

Completed

Interaction Between Reboxetine and 3,4-Methylenedioxymethamphetamine: Pharmacodynamics (PD) and Pharmacokinetics (PK)

Substance-related Disorders | Mood Disorder | Amphetamine-related Disorders

Switzerland
University of Zurich

Completed

Investigation of Serotonin Neurotransmission in MDMA Users Using Combinated Dexfenfluramine Challenge and PET Imaging (DEXFEN_PET)

Amphetamine-Related Disorders | Amphetamine Abuse

Switzerland
University of California, Los Angeles
National Institute on Drug Abuse (NIDA)

Completed

Study of Medical Treatment for Methamphetamine Addiction (BUP PGx)

Substance Abuse | Methamphetamine | Pharmacogenetics | Methamphetamine Dependence | Amphetamine Dependence

United States
Shanghai Mental Health Center

Completed

The Application of Cognitive Rehabilitation Therapy for Amphetamine-type Stimulants Addiction

Amphetamine Addiction

China
Universiti Sains Malaysia
Yale University

Unknown

An Open-label Study of Oral Paliparidone for the Treatment of Patients With Co-occurring Opioid and ATS Dependence

Heroin Dependence | Amphetamine Dependence

Malaysia
Universiti Sains Malaysia
Yale University

Unknown

An Open Label Study of Oral Minocycline for the Treatment of Patients With Co-occurring Opioid and ATS Dependence

Heroin Dependence | Amphetamine Dependence

Malaysia
Shanghai Mental Health Center
Yunnan Institute For Drug Abuse

Completed

Novel Intervention for Amphetamine-type Stimulants Addiction

Amphetamine Addiction

China
Universiti Sains Malaysia
Yale University

Unknown

Mirtazapine as a Treatment for Co-Occurring Opioid and ATS Dependence in Malaysia

Heroin Dependence | Amphetamine Dependence

Malaysia
Shanghai Mental Health Center

Completed

The Novel Addiction Assessment Study in Synthetic Drugs Addiction

Amphetamine Addiction

China
National Taiwan University Hospital Hsin-Chu Branch
National Health Research Institutes, Taiwan

Not yet recruiting

Non-invasive Brain Stimulation in Patients With Methamphetamine Use Disorder

Depression, Anxiety | Craving | Amphetamine Addiction
National Taiwan University Hospital
National Health Research Institutes, Taiwan

Completed

Repetitive Transcranial Magnetic Stimulation in Amphetamine Addiction

Depression, Anxiety | Craving | Amphetamine Addiction

Taiwan
National Cheng-Kung University Hospital
Ministry of Science and Technology, Taiwan

Recruiting

Dextromethorphan, Memantine Monotherapy, or Combined Use of Dextromethorphan and Memantine in Amphetamine Addiction

Amphetamine Addiction | Pharmacotherapy

Taiwan
University of California, Los Angeles
National Institute on Drug Abuse (NIDA)

Completed

An Assessment of the Safety of Varenicline in Methamphetamine-dependent Volunteers

Methamphetamine Addiction | Crystal Meth Addiction | Amphetamine Addiction

United States
University of Southern California
National Institute on Drug Abuse (NIDA); University of Toronto; RTI International

Completed

Change the Cycle: An RCT to Prevent Injection Initiation (CTC)

Substance Abuse, Intravenous | HIV | Heroin Dependence | Opioid Dependence | Cocaine Dependence | Amphetamine Dependence

United States
University Hospital, Basel, Switzerland

Completed

Pharmacological Interaction Between Doxazosin and Methylenedioxymethamphetamine (MDMA)

Substance-Related Disorders | Amphetamine-Related Disorders | Mood Disorder

Switzerland
University Hospital, Basel, Switzerland

Completed

Interaction Between Duloxetine and 3,4-Methylenedioxymethamphetamine (MDMA, Ecstasy)

Substance-Related Disorders | Amphetamine-Related Disorders | Mood Disorder

Switzerland
University Hospital, Basel, Switzerland

Completed

Pharmacological Interaction Between Carvedilol and Methylenedioxymethamphetamine (MDMA)

Substance-Related Disorders | Amphetamine-Related Disorders | Mood Disorder

Switzerland
University Hospital, Basel, Switzerland
Heffter Research Institute

Completed

Pharmacological Interaction Between Pindolol and MDMA (3,4-Methylenedioxymethamphetamine)

Substance-Related Disorders | Amphetamine-Related Disorders | Mood Disorder

Switzerland
National Health Research Institutes, Taiwan

Unknown

Implementation and Effectiveness of Multidiscipline-Integrated Addiction Treatment Model

Amphetamine-Related Disorders

Taiwan
National Institute on Drug Abuse (NIDA)

Unknown

A Phase 1 Parallel-Group, Double-Blind, Placebo-Controlled Cardiovascular and Behavioral Study Assessing Interactions Between Single Doses of Oral Reserpine and Intravenous Methamphetamine - 1

Amphetamine-Related Disorders

United States
University Hospital, Basel, Switzerland

Completed

Pharmacological Interaction Between Clonidine and Methylenedioxymethamphetamine (MDMA)

Substance-Related Disorders | Amphetamine-Related Disorders | Mood Disorder

Switzerland
Portland VA Research Foundation, Inc
Steven & Alexandra Cohen Foundation

Recruiting

Psilocybin-Enhanced Psychotherapy for Methamphetamine Use Disorder

Amphetamine-Related Disorders

United States
National Institute on Drug Abuse (NIDA)
University of Texas

Completed

Ondansetron for the Treatment of Methamphetamine Dependence - 1

Amphetamine-Related Disorders

United States
National Institute on Drug Abuse (NIDA)

Completed

Bupropion for the Treatment of Methamphetamine Dependence - 1

Amphetamine-Related Disorders

United States
National Institute on Drug Abuse (NIDA)

Unknown

Assessment of Potential Interactions Between Methamphetamine and Selegiline - 1

Amphetamine-Related Disorders

United States
National Institute on Drug Abuse (NIDA)

Unknown

To Assess the Safety and Tolerability of 7.5, 15 and 30 mg of Sublingual Lobeline. - 1

Amphetamine-Related Disorders

United States
National Institute on Drug Abuse (NIDA)

Unknown

Assessment of Interactions Between Intravenous Methamphetamine and Modafinil - 1

Amphetamine-Related Disorders

United States
California Pacific Medical Center Research Institute

Unknown

A Cognitive Behavioral Therapy-Based Text Message Intervention for Methamphetamine Dependence

Amphetamine-Related Disorders

United States
Hadassah Medical Organization

Completed

Functional Brain Imaging in Recreational Users of Ecstasy

Amphetamine-Related Disorders

Israel
Oregon Health and Science University
Affect Therapeutics, Inc.; CareOregon

Not yet recruiting

Hospital-Based Contingency Management

Amphetamine-Related Disorders
National Institute on Drug Abuse (NIDA)

Completed

Tyrosine for Methamphetamine Dependence - 1

Amphetamine-Related Disorders

United States
National Institute on Drug Abuse (NIDA)

Unknown

Assessment of Interactions Between Methamphetamine and Aripiprazole - 1

Amphetamine-Related Disorders

United States

Clinical Trials on Amphetamine Use Disorders

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Saudi Arabia

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations